Fiduciary Trust’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$237K Hold
25,999
﹤0.01% 751
2025
Q1
$207K Hold
25,999
﹤0.01% 780
2024
Q4
$141K Sell
25,999
-336
-1% -$1.82K ﹤0.01% 675
2024
Q3
$190K Hold
26,335
﹤0.01% 635
2024
Q2
$286K Hold
26,335
﹤0.01% 552
2024
Q1
$494K Buy
26,335
+440
+2% +$8.25K 0.01% 461
2023
Q4
$561K Sell
25,895
-20
-0.1% -$433 0.01% 431
2023
Q3
$533K Hold
25,915
0.01% 421
2023
Q2
$1.22M Sell
25,915
-25
-0.1% -$1.18K 0.02% 302
2023
Q1
$1.09M Hold
25,940
0.02% 313
2022
Q4
$989K Hold
25,940
0.02% 340
2022
Q3
$1.02M Sell
25,940
-50
-0.2% -$1.96K 0.02% 319
2022
Q2
$839K Hold
25,990
0.02% 354
2022
Q1
$860K Hold
25,990
0.02% 373
2021
Q4
$1.11M Sell
25,990
-10
-0% -$426 0.02% 335
2021
Q3
$1.15M Buy
26,000
+350
+1% +$15.5K 0.02% 315
2021
Q2
$1.46M Hold
25,650
0.03% 281
2021
Q1
$1.92M Sell
25,650
-25
-0.1% -$1.87K 0.04% 242
2020
Q4
$2.22M Hold
25,675
0.05% 228
2020
Q3
$1.57M Sell
25,675
-50
-0.2% -$3.06K 0.04% 241
2020
Q2
$1.07M Buy
25,725
+325
+1% +$13.5K 0.03% 266
2020
Q1
$729K Hold
25,400
0.02% 295
2019
Q4
$1.83M Hold
25,400
0.04% 215
2019
Q3
$3.56M Sell
25,400
-17
-0.1% -$2.39K 0.09% 150
2019
Q2
$4.65M Hold
25,417
0.12% 130
2019
Q1
$4.04M Buy
25,417
+17
+0.1% +$2.7K 0.11% 136
2018
Q4
$2.43M Buy
25,400
+2,000
+9% +$192K 0.07% 164
2018
Q3
$3.31M Hold
23,400
0.09% 155
2018
Q2
$3.66M Hold
23,400
0.11% 148
2018
Q1
$3.77M Buy
23,400
+4,289
+22% +$691K 0.12% 143
2017
Q4
$3.15M Buy
19,111
+3,424
+22% +$564K 0.09% 157
2017
Q3
$977K Buy
15,687
+6,000
+62% +$374K 0.03% 249
2017
Q2
$771K Sell
9,687
-1,197
-11% -$95.3K 0.02% 282
2017
Q1
$774K Buy
10,884
+2,687
+33% +$191K 0.02% 285
2016
Q4
$419K Hold
8,197
0.01% 344
2016
Q3
$377K Buy
+8,197
New +$377K 0.01% 353